Fantastic news from Relation, announcing a strategic collaboration with Novartis of up to $1.7 billion to discover and advance novel targets for atopic diseases. A powerful validation of the Relation platform and its growing momentum through mutliple high-value pharma partnerships.

This collaboration combines Relation’s AI-driven biology engine with Novartis’s deep immuno-dermatology expertise to develop novel therapies for patients living with atopic diseases.

In parallel, Relation has also secured an additional $26 million investment from existing investors, further strengthening its position to scale impact.

We are proud to be a significant investor and early partner to Relation, and we look forward to seeing the team continue to advance the platform and accelerate therapeutics to the patients who need them most.

Press release found here

Fierce Biotech coverage found here